$0.097
-0.010 (-10.19%)Zum Schluss
- High
- 0.105
- Open
- 0.090
- VWAP
- 0.10
- Vol
- 29.61M
- Mkt Cap
- 29.31M
- Low
- 0.085
- Amount
- 2.83M
- EV/EBITDA, TTM
- -6.64
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Analyst Ratings (4)
Piper Sandler
$1
2024-08-09
Piper Sandler
2024-08-09
Kursziel
$1
Stephens & Co.
$5
2024-08-09
Stephens & Co.
2024-08-09
Kursziel
$5
Stephens & Co.
$10
2024-06-25
Stephens & Co.
2024-06-25
Kursziel
$10
Piper Sandler
$3
2024-06-21
Piper Sandler
2024-06-21
Kursziel
$3
William Blair
—
2024-03-22
William Blair
2024-03-22
Kursziel
—
Bewertungskennzahlen
Event-Zeitleiste
News
9.005-01NewsfilterCutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure
4.503-11BenzingaUS Stocks Mixed; Kohl's Shares Plunge After Q4 Results
9.503-11BenzingaWhy Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
7.003-11NASDAQ.COMCutera Announces Voluntary Delisting From Nasdaq
- 2.003-10Newsfilter
Cutera Announces Voluntarily Delisting from Nasdaq
CUTR FAQ — answered by Alphio AI
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
4 analysts cover CUTR: 3 rate it Buy, 1 Hold and 0 Sell.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.